Next Article in Journal
The Role of Matrix Metalloproteinases in Thoracic Aortic Disease: Are They Indicators for the Pathogenesis of Dissections?
Next Article in Special Issue
Impact of Early Surfactant Administration on Ductus Arteriosus Assessed at 24 h in Preterm Neonates Less than 32 Weeks of Gestational Age
Previous Article in Journal
Associations of the CYP7A1 Gene Polymorphisms Located in the Promoter and Enhancer Regions with the Risk of Acute Coronary Syndrome, Plasma Cholesterol, and the Incidence of Diabetes
Previous Article in Special Issue
Dr. Tetsuro Fujiwara—My Memories from the Early Days of Dr. Fujiwara’s Research
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Application of Video Laryngoscopy for Minimally Invasive Surfactant Therapy: A Retrospective Comparative Cohort Study

by
Tamara Jahmani
1,
Michael R. Miller
1,2,
Orlando da Silva
1 and
Soume Bhattacharya
1,2,*
1
Department of Pediatrics, Western University, London, ON N6A 3K7, Canada
2
Children’s Health Research Institute, 800 Commissioners Road East, London, ON N6C 2V5, Canada
*
Author to whom correspondence should be addressed.
Biomedicines 2024, 12(3), 618; https://doi.org/10.3390/biomedicines12030618
Submission received: 30 January 2024 / Revised: 4 March 2024 / Accepted: 7 March 2024 / Published: 9 March 2024

Abstract

Minimally invasive surfactant therapy (MIST) has emerged as a preferred method of surfactant delivery. Pioneers of this technique have described the use of direct laryngoscopy (DL) for MIST. With the increasing application of video laryngoscopy (VL) for neonatal airway management, it is speculated that MIST techniques can be adapted for use with VL. Objective: To compare procedural success, operator ease of use, and complication of MIST using VL vs. MIST using DL. Methods: This was a retrospective, observational cohort study conducted at a tertiary-level neonatal intensive care unit after obtaining ethical approval. We included neonates who received MIST between 1 October 2020 and 31 October 2022. Baseline demographic characteristics, along with procedural data, were collected. Primary outcome measures included the overall procedural success rate, the need for multiple attempts, and the total number of attempts. Secondary outcome measures included the occurrence of adverse events, the need for a second dose of surfactant, and the need for intubation within 7 days of the procedure. Means and SDs, independent t-tests, frequencies, and chi-square were used as appropriate. p-values < 0.05 were considered statistically significant. Results: Of the 79 neonates included, 37 neonates received MIST via VL, while 42 received MIST via DL. The median gestational age was lower in the VL group at 29.0 weeks vs. 30.5 weeks (p = 0.011) in the DL group. The median birthweight in the VL group was 1260 g, IQR (1080, 1690), which was significantly lower than the DL group, which was 1575 g, IQR (1220, 2251), p = 0.028. Purpose-built catheter use was higher in the DL group. The overall procedural success was similar between groups. The need for multiple attempts was lower with VL in comparison to DL [4 (11%) vs. 13 (31%); p = 0.034)] at the univariate level but not significant at multivariate analysis (p = 0.131). Procedural complications, the need for a second dose of surfactant, the need for mechanical ventilation post-MIST, and operator ease of use were similar. User comments emphasized the value of VL in providing real-time visual information to confirm catheter placement and guide operators/trainees. Conclusion: Overall, in our cohort, despite VL being a more recently adapted technology used more in smaller, sicker, and more premature neonates, procedural success, complications, and operator ease of use for MIST using VL and DL were comparable. Our findings show the successful application of VL for MIST and suggest procedural advantages that might facilitate universal adoption.
Keywords: minimally invasive surfactant therapy (MIST); video laryngoscope; neonates; respiratory distress syndrome (RDS) minimally invasive surfactant therapy (MIST); video laryngoscope; neonates; respiratory distress syndrome (RDS)

Share and Cite

MDPI and ACS Style

Jahmani, T.; Miller, M.R.; da Silva, O.; Bhattacharya, S. Application of Video Laryngoscopy for Minimally Invasive Surfactant Therapy: A Retrospective Comparative Cohort Study. Biomedicines 2024, 12, 618. https://doi.org/10.3390/biomedicines12030618

AMA Style

Jahmani T, Miller MR, da Silva O, Bhattacharya S. Application of Video Laryngoscopy for Minimally Invasive Surfactant Therapy: A Retrospective Comparative Cohort Study. Biomedicines. 2024; 12(3):618. https://doi.org/10.3390/biomedicines12030618

Chicago/Turabian Style

Jahmani, Tamara, Michael R. Miller, Orlando da Silva, and Soume Bhattacharya. 2024. "Application of Video Laryngoscopy for Minimally Invasive Surfactant Therapy: A Retrospective Comparative Cohort Study" Biomedicines 12, no. 3: 618. https://doi.org/10.3390/biomedicines12030618

APA Style

Jahmani, T., Miller, M. R., da Silva, O., & Bhattacharya, S. (2024). Application of Video Laryngoscopy for Minimally Invasive Surfactant Therapy: A Retrospective Comparative Cohort Study. Biomedicines, 12(3), 618. https://doi.org/10.3390/biomedicines12030618

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop